| 货号 |
名称 |
纯度 |
CAS号 |
分子式 |
分子量 |
|
TD-AP198409
|
Acetyl -(DTrp1, DPhe(4-Cl)2, DTrp3, DArg6, DAla10)-LHRH
|
95%、98% |
86044-76-0 |
C₇₁H₉₄O₁₃N₁₉Cl₁ |
1457.08 |
|
TD-AP449745
|
缓激肽B2受体的选择性和特异性拮抗剂：艾替班特、Icatibant
|
|
130308-48-4 |
C₅₉H₈₉N₁₉O₁₃S |
1304.52 |
|
TD-AP135857
|
五肽JKC-301
|
|
136553-96-3 |
C₃₂H₄₄N₆O₇ |
624.73 |
|
TD-AP132940
|
环四肽：c(sPvLw)、c(D-Ser-Pro-D-Val-Leu-D-Trp)
|
|
153982-38-8 |
C₃₀H₄₂N₆O₆ |
582.69 |
|
TD-AP179063
|
拮抗性 Bombesin 类似物：NOTA-P2-RM26
|
95%、98% |
1446005-10-2 |
C₇₃H₁₁₀N₁₈O₁₉ |
1543.76 |
|
TD-AP438184
|
第四代GnRH拮抗剂、Ozarelix
|
|
295350-45-7/896710-46-6 |
C₇₂H₉₆ClN₁₇O₁₄ |
1459.09 |
|
TD-AP437263
|
PMX 205
|
|
514814-49-4 |
|
|
|
TD-AP130950
|
RAGE antagonist peptide
|
|
1092460-91-7 |
C₅₇H₁₀₁O₁₇N₁₃S₁ |
1272.55 |
|
TD-AP142679
|
S961
|
|
1083433-49-1 |
C₂₁₁H₂₉₅N₅₅O₇₁S₂ |
4802.06 |
|
TD-AP437267
|
tcY-NH2
|
|
327177-34-4/1262750-73-1 |
|
|
|
TD-AP431294
|
VIP受体拮抗剂： [(4Cl)DPhe6, Leu17] VIP
|
|
102805-45-8 |
|
|
|
TD-AP146230
|
TNF-α Antagonist
|
|
199999-60-5 |
C₅₈H₇₁N₁₁O₁₅S₂ |
1226.38 |
|
TD-AP157511
|
肾上腺皮质素释放因子拮抗剂：α-helical CRF 9-41
|
95%、98% |
99658-03-4/90880-23-2 |
C₁₆₆H₂₇₄N₄₆O₅₃S₂ |
3826.36 |
|
TD-AP200588
|
六肽G-Protein antagonist peptide
|
|
|
C₅₇H₆₄N₁₂O₉S₁ |
1093.26 |
|
TD-AP182956
|
Astressin、(D-Phe¹²,Nle²¹·³⁸,cyclo(Glu³⁰-Lys³³))-CRF (12-41) (human, rat)
|
95%、98% |
170809-51-5 |
C₁₆₁H₂₆₉N₄₉O₄₂ |
3563.16 |
|
TD-AP126811
|
阿片受体拮抗剂3：Acetalin 3, Opioid Receptor Antagonist 3
|
95%、98% |
152274-67-4 |
C₄₄H₆₆O₇N₁₂S₂ |
939.2 |
|
TD-AP146315
|
阿片受体拮抗剂2：Acetalin 2, Opioid Receptor Antagonist 2
|
95%、98% |
152274-66-3 |
C₄₄H₆₆O₇N₁₄S₂ |
967.21 |
|
TD-AP184784
|
阿片受体拮抗剂1：Acetalin 1, Opioid Receptor Antagonist 1
|
95%、98% |
152274-65-2 |
C₄₂H₆₁O₈N₁₁S₂ |
912.13 |
|
TD-AP431652
|
Somatostatin Antagonist、Cyclosomatostatin
|
|
84211-54-1/211056-95-0 |
|
779.98 |
|
TD-AP566145
|
新型DOTA偶联GRPR拮抗剂：NeoBOMB1
|
|
2255342-28-8 |
|
|
抗体
试剂盒
多肽
蛋白
组织芯片
